Verona Pharma PLC
F:I9SA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Verona Pharma PLC
F:I9SA
|
UK |
|
M
|
MaxCyte Inc
NASDAQ:MXCT
|
US |
|
PKSHA Technology Inc
F:762
|
JP |
|
S
|
Shangri-La Asia Ltd
F:SHN
|
HK |
|
A
|
Air Products and Chemicals Inc
XMUN:AP3
|
US |
|
Firstcash Holdings Inc
F:FF60
|
US |
|
M
|
Merck & Co Inc
XBER:6MK
|
US |
|
I
|
International Consolidated Airlines Group SA
MAD:IAG
|
UK |
|
A
|
Analog Devices Inc
DUS:ANL
|
US |
|
N
|
Nomura Holdings Inc
DUS:NSE
|
JP |
|
S
|
Seven & i Holdings Co Ltd
XMUN:S6M
|
JP |
|
A
|
American Campus Communities Inc
F:FGA
|
US |
|
Recruit Holdings Co Ltd
F:1RH
|
JP |
|
CareCloud Inc
F:MTB0
|
US |
|
V
|
Vail Resorts Inc
SWB:VAI
|
US |
|
C
|
CompuGroup Medical SE & Co KgaA
XBER:COP
|
DE |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is I9SA's stock price target?
Not Available
I9SA does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Verona Pharma PLC?
Projected CAGR
202%
The compound annual growth rate for Revenue over the next 3 years is 202%.